Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 93 M99 M97 M94 M90 M 380 M Research & development ————— — Operating income 521 M506 M525 M523 M465 M 2.02 B Non-Operating Income, Total 4 M6 M3 M3 M2 M 14 M Interest expense, net of interest capitalized 241 M247 M252 M247 M246 M 992 M Non-Operating Income, excl. Interest Expenses -238 M-243 M-249 M-244 M-243 M -979 M Unusual income/expense 1 M2 M00-1 M 1 M Pretax income 289 M269 M281 M280 M225 M 1.05 B Equity in earnings ————— — Taxes 5 M4 M4 M3 M5 M 16 M Non-controlling/minority interest ————— — After tax other income/expense -1 M-3 M08 M1 M 6 M Net income before discontinued operations -546 M13 M46 M15 M-125 M -51 M Discontinued operations 82 M278 M277 M279 M276 M 1.11 B Net income -464 M291 M323 M294 M151 M 1.06 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -464 M291 M323 M294 M151 M 1.06 B Basic earnings per share (Basic EPS) -1.070.670.740.680.34 2.43 Diluted earnings per share (Diluted EPS) -1.070.670.740.670.34 2.42 Average basic shares outstanding 435 M435 M435 M435 M436 M — Diluted shares outstanding 436 M437 M437 M437 M437 M — EBITDA 529 M514 M533 M708 M472 M 2.23 B EBIT 521 M506 M525 M523 M465 M 2.02 B Cost of revenue 28 M27 M30 M28 M26 M 111 M Other cost of goods sold 240 M251 M250 M251 M240 M 992 M Depreciation & amortization (cash flow) 8 M8 M8 M185 M7 M 208 M